Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
14.69
+0.28 (1.94%)
Apr 27, 2026, 10:53 AM EDT - Market open
Trevi Therapeutics Employees
Trevi Therapeutics had 34 employees as of December 31, 2025. The number of employees increased by 8 or 30.77% compared to the previous year.
Employees
34
Change (1Y)
8
Growth (1Y)
30.77%
Revenue / Employee
n/a
Profits / Employee
-$1,257,618
Market Cap
2.06B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | 8 | 30.77% |
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | 0 | - |
| Dec 31, 2022 | 25 | 1 | 4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Adaptive Biotechnologies | 624 |
| Galapagos NV | 558 |
| Ocular Therapeutix | 325 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Stoke Therapeutics | 170 |
TRVI News
- 3 days ago - Trevi Therapeutics to Participate in Upcoming May Events - GlobeNewsWire
- 6 days ago - Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - GlobeNewsWire
- 9 days ago - What's Going On With Trevi Therapeutics Stock? - Benzinga
- 10 days ago - Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 10 days ago - Trevi Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 26 days ago - Trevi Therapeutics to Participate in Upcoming Events - GlobeNewsWire
- 5 weeks ago - Trevi Therapeutics Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates - GlobeNewsWire